Roche Holding AG
RHO5
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
103,249
Roche Holding AG News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,288.10 | 53.60 | 0.58% |
| CAC 40 | 8,081.54 | 24.91 | 0.31% |
| DAX 40 | 24,378.80 | 43.76 | -0.18% |
| Dow JONES (US) | 46,758.28 | 238.56 | 0.51% |
| FTSE 100 | 9,491.25 | 63.52 | 0.67% |
| HKSE | 27,140.92 | 146.20 | -0.54% |
| NASDAQ | 22,780.51 | 63.54 | -0.28% |
| Nikkei 225 | 45,769.50 | 832.77 | 1.85% |
| NZX 50 Index | 13,514.09 | 62.33 | 0.46% |
| S&P 500 | 6,715.79 | 0.44 | 0.01% |
| S&P/ASX 200 | 8,987.40 | 50.80 | 0.57% |
| SSE Composite Index | 3,882.78 | 20.25 | 0.52% |